Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ONWARD Medical logo — Empowering Movement

ONWARD Medical

Empowering Movement

Founded 2014 The Netherlands The Netherlands 208 employees Post-IPO Debt Total: $136.47M Biotechnology, Health Care +3

General Information

Company Name ONWARD Medical
Founded Year 2014
Location The Netherlands The Netherlands
Employees 208
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Post-IPO Debt
Hiring 4 roles posted in the month to 25 Sep 2026
Social

BounceWatch is an independent company data service, not affiliated with ONWARD Medical. To contact ONWARD Medical, visit onwd.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ONWARD Medical compare?

A PDF of ONWARD Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ONWARD Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Award Received Sep 23, 2026

ONWARD Medical was featured among #BCI innovators in the Financial Times' latest article on brain-computer interfaces.

Event Participation Sep 15, 2026

ONWARD Medical will be attending the International Spinal Cord Society - ISCOS Annual Scientific Meeting from October 7-10, 2026 in Kuala Lumpur, Malaysia, where they will also host a Lunch Symposium.

Actively Hiring Sep 14, 2026

Hiring for 4 positions in the last 30 days.

Growth Metrics Sep 09, 2026

ONWARD Medical reported strong revenue growth for the first half of 2026.

Major Customer Win Sep 08, 2026

ONWARD Medical's ARC-EX® System is being integrated by the Abilities Research Center at the Icahn School of Medicine at Mount Sinai to support rehabilitation for people with spinal cord injuries.

Get alerts when ONWARD Medical shows new signals

About ONWARD Medical

Onward is a medical technology startup with a mission to restore movement, function, and independence in individuals with spinal cord injuries. The company's innovative ARC Therapy, offered through implantable (ARC-IM) or external (ARC-EX) systems, delivers targeted spinal cord stimulation to enhance movement and other functions, aiming to improve the quality of life for those with spinal cord injuries. Notably, Onward Medical has received nine Breakthrough Device Designations from the U.S. FDA for both ARC-IM and ARC-EX. The company reported positive top-line data from its pivotal study, Up-LIFT, assessing the efficacy of transcutaneous ARC Therapy to enhance upper extremity strength and function. Onward Medical has completed its first-in-human use of the ARC-IM neurostimulator and is now preparing marketing approval submissions for the U.S. and Europe. Founded in 2014, Onward Medical is based in Eindhoven, the Netherlands, with a Science and Engineering Center located in Lausanne, Switzerland, and a growing presence in the U.S. in Boston, Massachusetts. The company has a notable academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV). In March 2024, Onward Medical secured a significant €20.00MPost-IPO Equity investment. The investors involved in this funding round include Life Science Partners, Inkef, Grégoire Courtine, Kristina Dziekan, Fred Colen, Lorenzo Fanti, Robert O'Dell, Ian Curtis, Dave Marver, and Jocelyne Bloch. This recent investment demonstrates the confidence that prominent industry professionals and investment firms place in Onward Medical's innovative technologies and its potential to make a meaningful impact in the biotechnology and healthcare industries.

Taxonomy: spinal cord injuries, neuroscience, spinal cord stimulation, FDA Breakthrough Device Designations, implantable technology, external stimulation, pivotal study, transcutaneous therapy, neurostimulator, academic partnership, rehabilitation, neurological disorders, real-time motion feedback, training tools

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €52.50M 1
Runway Growth Capital
Runway Growth Capital
28 Jun 2024
Post IPO Equity €20.00M 10
GIMV Wellington Partners Invest-NL
GIMV, Wellington Partners +8
20 Mar 2024
Grant €1.20M 1
European Innovation Council
European Innovation Council
16 Jun 2022
Venture Round €26.54M 6
GIMV Wellington Partners Invest-NL
GIMV, Wellington Partners +4
22 Apr 2021
Grant Undisclosed 1
Eurostars
19 Mar 2019
Debt Financing €10.00M 1
Netherlands Enterprise Agency
Netherlands Enterprise Agency
19 Apr 2016
Series A €26.00M 4
GIMV Wellington Partners Inkef
GIMV, Wellington Partners +2
19 Apr 2016
Grant Undisclosed 1
MassChallenge
MassChallenge
01 Nov 2014
Grant €100.00K -
22 Apr 2014
Grant Fr.20.00K 1
Venture Kick
Venture Kick
05 Feb 2014

View All 12 Funding Rounds

ONWARD Medical Alternatives & Competitors

ONWARD Medical vs
Ulevo Health
Ulevo Health

Lightweight, personalized devices designed to detect and reduce muscle spasms linked to neurological...

Pre-Seed
Health Care, Medical Devices

FAQ About ONWARD Medical

Empowering Movement
ONWARD Medical was founded in 2014.
ONWARD Medical is headquartered in The Netherlands.
ONWARD Medical operates in Biotechnology, Health Care, Health and Wellness, Manufacturing and Medical Devices. Its work centres on spinal cord injuries, neuroscience, spinal cord stimulation and FDA Breakthrough Device Designations.
ONWARD Medical has approximately 208 employees.
ONWARD Medical has completed 12 funding rounds, raising a total of $136.47M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to ONWARD Medical include Ulevo Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ONWARD Medical and Ulevo Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ONWARD Medical, https://bouncewatch.com/company/onward-2, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes